Loading...
INmune Bio, Inc.
INMB•NASDAQ
Healthcare
Biotechnology
$2.15
$-4.13(-65.76%)
INmune Bio, Inc. (INMB) Financial Performance & Statements
Review INmune Bio, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-90.97%
↓ 90.97%
Operating Income Growth
-43.35%
↓ 43.35%
Net Income Growth
-40.24%
↓ 40.24%
Operating Cash Flow Growth
-178.47%
↓ 178.47%
Operating Margin
-83046.00%
↓ 83046.00%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-81592.00%
↓ 81592.00%
ROE
-118.66%
↓ 118.66%
ROIC
-138.99%
↓ 138.99%
INmune Bio, Inc. (INMB) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for INmune Bio, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $14000.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $14000.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $1.00 |
| R&D Expenses | $7.35M | $10.07M | $7.05M | $8.69M |
| SG&A Expenses | $2.11M | $2.22M | $2.81M | $2.34M |
| Operating Expenses | $9.47M | $12.29M | $9.87M | $11.03M |
| Total Costs & Expenses | $9.47M | $12.29M | $9.87M | $11.03M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $9.87M | $11.02M |
| EBITDA | -$9.47M | -$12.29M | -$9.87M | $0.00 |
| EBITDA Ratio | $0.00 | |||
| Operating Income | -$9.47M | -$12.29M | -$9.87M | -$11.02M |
| Operating Income Ratio | -$786.93 | |||
| Other Income/Expenses (Net) | $249000.00 | $193000.00 | $119000.00 | -$8000.00 |
| Income Before Tax | -$9.22M | -$12.09M | -$9.75M | -$11.03M |
| Income Before Tax Ratio | -$787.50 | |||
| Income Tax Expense | $0.00 | $0.00 | -$9.87M | -$11.02M |
| Net Income | -$9.22M | -$12.09M | -$9.75M | -$11.03M |
| Net Income Ratio | -$787.50 | |||
| EPS | -$0.46 | -$0.60 | -$0.50 | -$0.61 |
| Diluted EPS | -$0.46 | -$0.60 | -$0.50 | -$0.61 |
| Weighted Avg Shares Outstanding | $22.28M | $20.19M | $19.31M | $18.03M |
| Weighted Avg Shares Outstanding (Diluted) | $22.28M | $20.19M | $19.31M | $18.03M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan